Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Brian Elsbernd | Chief ComplianceLegal Officer | 2024-03-27 | 25,000 | $16.44 | $411.00kSell |
Donald A. Denkhaus | Director | 2024-02-05 | 40,000 | $4.01 | $160.40kBuy |
Patrick J. McEnany | Director | 2024-01-02 | 250,000 | $1.13 | $282.50kBuy |
David S. Tierney | Director | 2024-01-02 | 10,000 | $1.13 | $11.30kBuy |
Charles B. Okeeffe | Director | 2024-01-02 | 60,000 | $1.13 | $67.80kBuy |
Molly Harper | Director | 2023-12-15 | 4,000 | $14.43 | $57.72kSell |
Molly Harper | Director | 2023-12-15 | 10,000 | $5.78 | $57.80kBuy |
Molly Harper | Director | 2023-12-15 | 10,000 | $14.37 | $143.70kSell |
David S. Tierney | Director | 2023-12-12 | 50,000 | $1.13 | $56.50kBuy |
David S. Tierney | Director | 2023-12-12 | 50,000 | $13.33 | $666.25kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Blackrock Inc | 13.42% | 15,822,299 | $257.43M | Institution |
Deerfield Management Company LP Series C | 7.54% | 8,888,901 | $144.62M | Institution |
Vanguard Group Inc | 6.04% | 7,120,417 | $115.85M | Institution |
State Street Corp | 5.76% | 6,787,332 | $110.43M | Institution |
Biomarin Pharmaceutical Inc | 5.66% | 6,666,667 | $108.47M | Insider |
Patrick J. McEnany | 4.21% | 4,966,021 | $80.80M | Insider |
Hubert E. Md Huckel | 3.22% | 3,793,238 | $61.72M | Insider |
Dimensional Fund Advisors LP | 2.21% | 2,601,797 | $42.33M | Institution |
Geode Capital Management LLC | 1.87% | 2,200,225 | $35.80M | Institution |
Morgan Stanley | 1.66% | 1,961,539 | $31.91M | Institution |